Company news
Savara, Inc. news in 2020
Savara, Inc.'s news releases, calls and decks from 2020, newest first.
Savara Provides Pipeline and Business Update
December 9, 2020
Savara Announces Participation in Fireside Chats at Two Upcoming Virtual Investor Healthcare Conferences
November 23, 2020
Savara to Present at the Jefferies Virtual London Healthcare Conference
November 10, 2020
Savara Reports Third Quarter 2020 Financial Results and Provides Business Update
November 4, 2020
Savara Announces Senior Management Changes
September 10, 2020
Savara to Present at the 22nd Annual H.C. Wainwright Annual Investment Conference Being Held Virtually
September 8, 2020
Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results
September 7, 2020
Savara to Discontinue Exploratory ENCORE Study Evaluating Molgradex for the Treatment of NTM Lung Infection in People Living With Cystic Fibrosis (CF)
September 2, 2020
Savara Reports Second Quarter 2020 Financial Results and Provides Business Update
August 5, 2020
Savara to Present at the 40th Annual Canaccord Genuity Global Growth Conference to be Held Virtually
August 4, 2020
Savara to Report Second Quarter 2020 Financial Results and Provide Business Update
July 29, 2020
Savara to Present at the Jefferies Virtual Healthcare Conference
May 26, 2020
Savara Announces Change of Date for 2020 Annual Meeting of Stockholders
May 7, 2020
Savara Reports First Quarter 2020 Financial Results and Provides Business Update
May 6, 2020
Savara to Report First Quarter 2020 Financial Results and Provide Business Update
April 29, 2020
Savara Obtains Global Rights to Develop and Commercialize Apulmiq
April 1, 2020
Savara Provides Business Update in Response to COVID-19 Pandemic
March 29, 2020
Savara Reports Fourth Quarter / Year-End 2019 Financial Results and Provides Business Update
March 11, 2020
Savara to Report Fourth Quarter/Year-End 2019 Financial Results and Provide Business Update
March 4, 2020